Drug
Depatuxizumab clinical trials
Also written ABT-806.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
AbbVie (prior sponsor, Abbott) (3) · University of Chicago (1)
Often tested with
Tested in the same studies.
Trastuzumab (1) · Bemarituzumab (1) · Ramucirumab (1) · Nivolumab (1) · ABT-806I (1)
Studies
Open first, then newest update. How each study uses depatuxizumab is read from its arms, and is right about nine times in ten.
Testing it · 4
- PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond ProgressionCompletedPhase 2University of ChicagoNCT02213289Written as ABT-806
- A Study of ABT-806 in Subjects With Advanced Solid Tumor TypesCompletedPhase 1AbbVie (prior sponsor, Abbott)NCT01255657Written as ABT-806
- An Extension Study of ABT-806 in Subjects With Advanced Solid TumorsCompletedPhase 1AbbVie (prior sponsor, Abbott)NCT01406119Written as ABT-806
- An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor TypesCompletedPhase 1AbbVie (prior sponsor, Abbott)NCT01472003Written as ABT-806
Codes
What other systems call depatuxizumab · ClinicalTrials.gg INT000389
- MeSH (NLM) C000604456depatuxizumabOne source NLM
- UNII (FDA) W984C353CGDEPATUXIZUMABConfirmed FDA, NLM
- NCI Thesaurus C95206DepatuxizumabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000604456 | depatuxizumab | One source NLM |
| UNII (FDA) | W984C353CG | DEPATUXIZUMAB | Confirmed FDA, NLM |
| NCI Thesaurus | C95206 | Depatuxizumab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.